APP and Cognitive impairment: Evidence from a series of recent experiments revealed that AQP-4 is responsible for bulk ISF flow in the glymphatic system, and its deletion resulted in Aβ deposition, aggravation of cognitive impairment, and induction of cerebral amyloid angiopathy in APP/PS1 mice [42,43].